Carl Genberg
Directeur Technique/Scientifique/R&D chez Ceragenix Corp.
Profil
Carl Genberg currently works at Ceragenix Corp., as Senior Vice President-Research & Development from 2002.
Mr. Genberg also formerly worked at N8 Medical, Inc., as Chief Executive Officer, OnSource Corp., as Senior Vice President, and Ceragenix Pharmaceuticals, Inc., as SVP-Research & Development from 2005 to 2010.
Mr. Genberg received his undergraduate degree from Cornell University.
Postes actifs de Carl Genberg
| Sociétés | Poste | Début |
|---|---|---|
| Ceragenix Corp. | Directeur Technique/Scientifique/R&D | 01/02/2002 |
Anciens postes connus de Carl Genberg
| Sociétés | Poste | Fin |
|---|---|---|
N8 Medical, Inc.
 N8 Medical, Inc. Medical SpecialtiesHealth Technology N8 Medical, Inc. is an American clinical stage biotechnology company that develops anti-fouling medical devices to reduce infections, complications, and mortality. The private company is based in an undisclosed location and has a platform technology called Cerashield™, which is based on ceragenins, a novel compound invented by Professor Paul B. Savage. The technology has been featured in over 90 peer-reviewed journal articles. Marc H. Rohman has been the CEO of the company since 2019. | Directeur Général | 01/06/2019 |
Ceragenix Pharmaceuticals, Inc.
 Ceragenix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ceragenix Pharmaceuticals, Inc. operates as a biopharmaceutical company. It focuses on infectious disease and dermatology. It offers two base technologies: Ceragenins and Barrier Repair. The Ceragenins is used for the treatment of infectious disease and Barrier Repair Technology is used for the treatment of dermatological disorders, including atopic dermatitis, neonatal skin disorders and others. The company was founded in 2002 and is headquartered in Denver, CO. | Directeur Technique/Scientifique/R&D | 29/03/2010 |
| OnSource Corp. | Corporate Officer/Principal | 27/06/2005 |
Formation de Carl Genberg
| Cornell University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
| OnSource Corp. | Consumer Services |
Ceragenix Pharmaceuticals, Inc.
Ceragenix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ceragenix Pharmaceuticals, Inc. operates as a biopharmaceutical company. It focuses on infectious disease and dermatology. It offers two base technologies: Ceragenins and Barrier Repair. The Ceragenins is used for the treatment of infectious disease and Barrier Repair Technology is used for the treatment of dermatological disorders, including atopic dermatitis, neonatal skin disorders and others. The company was founded in 2002 and is headquartered in Denver, CO. | Health Technology |
| Ceragenix Corp. | |
N8 Medical, Inc.
N8 Medical, Inc. Medical SpecialtiesHealth Technology N8 Medical, Inc. is an American clinical stage biotechnology company that develops anti-fouling medical devices to reduce infections, complications, and mortality. The private company is based in an undisclosed location and has a platform technology called Cerashield™, which is based on ceragenins, a novel compound invented by Professor Paul B. Savage. The technology has been featured in over 90 peer-reviewed journal articles. Marc H. Rohman has been the CEO of the company since 2019. | Health Technology |